Cardioloxía

2013

1. 2013 ESC guidelines on the management of stable coronary artery disease

   European Heart Journal, Vol. 34, Núm. 38, pp. 2949-3003

2. A 58-year old male referred for consultation due to pathological ECG finding

   Medicine (Spain), Vol. 11, Núm. 42

3. A comparison of the CKD-EPI, MDRD-4, and Cockcroft-Gault equations to assess renal function in predicting all-cause mortality in acute coronary syndrome patients

   International Journal of Cardiology, Vol. 167, Núm. 5, pp. 2325-2326

4. A novel electrocardiographic index for the diagnosis of diastolic dysfunction

   PLoS ONE, Vol. 8, Núm. 11

5. Abluminal biodegradable polymer biolimus-eluting stent versus durable polymer everolimus-eluting stent (COMPARE II): A randomised, controlled, non-inferiority trial

   The Lancet, Vol. 381, Núm. 9867, pp. 651-660

6. Acceso radial frente a femoral después de una intervención coronaria percutánea en infarto agudo de miocardio con elevación del segmento ST. Resultados de mortalidad a 30 días y a 1 año

   Revista Espanola de Cardiologia, Vol. 66, Núm. 11, pp. 871-878

7. Actualización en cardiopatía isquémica y cuidados críticos cardiológicos

   Revista Espanola de Cardiologia, Vol. 66, Núm. 3, pp. 198-204

8. Adiponectin and resistin serum levels in non-diabetic ankylosing spondylitis patients undergoing TNF-α antagonist therapy

   Clinical and Experimental Rheumatology, Vol. 31, Núm. 3, pp. 365-371

9. Alteraciones electrocardiográficas en un breve espacio de tiempo

   Cadernos de atención primaria, Vol. 19, Núm. 3, pp. 202-208

10. Angiopoietin-2 serum levels correlate with severity, early onset and cardiovascular disease in patients with rheumatoid arthritis

    Clinical and Experimental Rheumatology, Vol. 31, Núm. 5, pp. 761-766

11. Apelin serum levels in non-diabetic ankylosing spondylitis patients undergoing TNF-α antagonist therapy

    Clinical and Experimental Rheumatology, Vol. 31, Núm. 4, pp. 532-537

12. Are hospitalized or ambulatory patients with heart failure treated in accordance with European Society of Cardiology guidelines? Evidence from 12 440 patients of the ESC Heart Failure Long-Term Registry

    European Journal of Heart Failure, Vol. 15, Núm. 10, pp. 1173-1184

13. Are some of the last advances in cardiovascular therapeutics fighting against the historic evolution of the heart and the cardiovascular system?

    International Journal of Cardiology, Vol. 168, Núm. 4, pp. 4276-4277

14. Arritmias

    Medicine (Spain), Vol. 11, Núm. 38, pp. 2281-2287

15. Arritmias

    Medicine: Programa de Formación Médica Continuada Acreditado, Serie 11, Núm. 38, pp. 2281-2287

16. Asymmetric dimethylarginine serum levels in non-diabetic ankylosing spondylitis patients undergoing TNF-α antagonist therapy

    Clinical and Experimental Rheumatology, Vol. 31, Núm. 5, pp. 749-755

17. Atrial fibrillation outcomes: Changing the paradigm

    International Journal of Cardiology, Vol. 166, Núm. 2, pp. 545-547

18. Availability and characteristics of cardiovascular rehabilitation programs in South America

    Journal of Cardiopulmonary Rehabilitation and Prevention, Vol. 33, Núm. 1, pp. 33-41

19. Benefits of delapril in hypertensive patients along the cardiovascular continuum

    Expert Review of Cardiovascular Therapy, Vol. 11, Núm. 3, pp. 271-281

20. Bochdalek hernia causing pulmonary hypertension

    Circulation, Vol. 127, Núm. 17, pp. 1837-1839